1. Academic Validation
  2. A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling

A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling

  • Nat Commun. 2022 Jan 21;13(1):438. doi: 10.1038/s41467-022-28096-z.
Qian Yuan # 1 Qian Ren # 1 Li Li # 1 Huishi Tan 1 Meizhi Lu 1 Yuan Tian 1 Lu Huang 2 Boxin Zhao 3 Haiyan Fu 1 Fan Fan Hou 1 4 Lili Zhou 5 6 Youhua Liu 7 8 9
Affiliations

Affiliations

  • 1 State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • 2 Analysis and Test Center, Guangdong University of Technology, Guangzhou, China.
  • 3 Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • 4 Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China.
  • 5 State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. [email protected].
  • 6 Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China. [email protected].
  • 7 State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. [email protected].
  • 8 Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China. [email protected].
  • 9 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. [email protected].
  • # Contributed equally.
Abstract

Loss of Klotho, an Anti-aging protein, plays a critical role in the pathogenesis of chronic kidney diseases. As Klotho is a large transmembrane protein, it is challenging to harness it as a therapeutic remedy. Here we report the discovery of a Klotho-derived peptide 1 (KP1) protecting kidneys by targeting TGF-β signaling. By screening a series of Peptides derived from human Klotho protein, we identified KP1 that repressed fibroblast activation by binding to TGF-β Receptor 2 (TβR2) and disrupting the TGF-β/TβR2 engagement. As such, KP1 blocked TGF-β-induced activation of SMAD2/3 and mitogen-activated protein kinases. In mouse models of renal fibrosis, intravenous injection of KP1 resulted in its preferential accumulation in injured kidneys. KP1 preserved kidney function, repressed TGF-β signaling, ameliorated renal fibrosis and restored endogenous Klotho expression. Together, our findings suggest that KP1 recapitulates the anti-fibrotic action of Klotho and offers a potential remedy in the fight against fibrotic kidney diseases.

Figures
Products